Crossmark

Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus

Crossref DOI link: https://doi.org/10.1186/s12882-018-0942-1

Published Online: 2018-06-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Go, Alan S. http://orcid.org/0000-0001-9109-0811
Yang, Jingrong

Tan, Thida C.

Cabrera, Claudia S.

Stefansson, Bergur V.

Greasley, Peter J.

Ordonez, Juan D.
Funding

Funding for this research was provided by:

AstraZeneca
License Information

Text and Data Mining valid from 2018-06-22
More Information

Article History

Received: 18 September 2017

Accepted: 7 June 2018

First Online: 22 June 2018

Ethics approval and consent to participate

: This study was approved by the Kaiser Permanente Northern California institutional review board. A waiver of consent was obtained due to the nature of the study.

: Not applicable.

: Drs. Cabrera, Stefansson and Greasley are employees of Astra-Zeneca. Ms. Yang, Ms. Tan and Dr. Ordonez declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.